PubMed:24737316 / 306-592 JSONTXT

{"project":"sentences","denotations":[{"id":"T3","span":{"begin":0,"end":286},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Pharmacological chaperone (PC) therapy is a newly developed molecular therapeutic approach by using small molecule ligands of the mutant enzyme that are able to promote the correct folding and prevent endoplasmic reticulum-associated degradation and promote trafficking to the lysosome."}

{"project":"Allie","denotations":[{"id":"SS1_24737316_2_0","span":{"begin":0,"end":25},"obj":"expanded"},{"id":"SS2_24737316_2_0","span":{"begin":27,"end":29},"obj":"abbr"}],"relations":[{"id":"AE1_24737316_2_0","pred":"abbreviatedTo","subj":"SS1_24737316_2_0","obj":"SS2_24737316_2_0"}],"text":"Pharmacological chaperone (PC) therapy is a newly developed molecular therapeutic approach by using small molecule ligands of the mutant enzyme that are able to promote the correct folding and prevent endoplasmic reticulum-associated degradation and promote trafficking to the lysosome."}

{"project":"GlyCosmos15-UBERON","denotations":[{"id":"T2","span":{"begin":213,"end":222},"obj":"Body_part"},{"id":"T3","span":{"begin":277,"end":285},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0007361"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/GO_0005764"}],"text":"Pharmacological chaperone (PC) therapy is a newly developed molecular therapeutic approach by using small molecule ligands of the mutant enzyme that are able to promote the correct folding and prevent endoplasmic reticulum-associated degradation and promote trafficking to the lysosome."}

{"project":"sentences","denotations":[{"id":"T3","span":{"begin":0,"end":286},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Pharmacological chaperone (PC) therapy is a newly developed molecular therapeutic approach by using small molecule ligands of the mutant enzyme that are able to promote the correct folding and prevent endoplasmic reticulum-associated degradation and promote trafficking to the lysosome."}

{"project":"GlyCosmos15-Sentences","blocks":[{"id":"T3","span":{"begin":0,"end":286},"obj":"Sentence"}],"text":"Pharmacological chaperone (PC) therapy is a newly developed molecular therapeutic approach by using small molecule ligands of the mutant enzyme that are able to promote the correct folding and prevent endoplasmic reticulum-associated degradation and promote trafficking to the lysosome."}

{"project":"Anatomy-UBERON","denotations":[{"id":"T2","span":{"begin":213,"end":222},"obj":"Body_part"},{"id":"T3","span":{"begin":277,"end":285},"obj":"Body_part"}],"attributes":[{"id":"A2","pred":"uberon_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/UBERON_0007361"},{"id":"A3","pred":"uberon_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/GO_0005764"}],"text":"Pharmacological chaperone (PC) therapy is a newly developed molecular therapeutic approach by using small molecule ligands of the mutant enzyme that are able to promote the correct folding and prevent endoplasmic reticulum-associated degradation and promote trafficking to the lysosome."}